Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16604
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEkinci, Elif I-
dc.contributor.authorTorkamani, Niloufar-
dc.contributor.authorRamchand, Sabashini K-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorSikaris, Ken A-
dc.contributor.authorLu, Zhong X-
dc.contributor.authorHoulihan, Christine A-
dc.date2017-01-27-
dc.date.accessioned2017-03-16T03:06:23Z-
dc.date.available2017-03-16T03:06:23Z-
dc.date.issued2017-09-
dc.identifier.citationJournal of Diabetes Investigation 2017; 8(5): 697-700en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16604-
dc.description.abstractIt is unknown if high prolactin levels during pregnancy contribute to the development of gestational diabetes. We hypothesized that higher prolactin levels are associated with reduced glucose tolerance, as determined by higher 2-hour glucose level from an oral glucose tolerance test (OGTT) in pregnancy. 75 gram OGTT was performed at 28 weeks of gestation in 69 participants. A multiple regression analysis was used to determine the relationship between serum prolactin and 2-hour glucose levels. Multivariable regression analysis demonstrated an independent and significant relationship between third trimester prolactin and 2-hour glucose levels post OGTT. Higher prolactin levels were associated with higher glucose levels independent of age, BMI, gravidity and parity. Higher prolactin levels associated with reduced glucose tolerance in the third trimester of pregnancy suggests possible independent role of prolactin in the pathogenesis of gestational diabetes.en_US
dc.subjectGestational Diabetes Mellitusen_US
dc.subjectMaternal Glycaemiaen_US
dc.subjectPregnancyen_US
dc.titleHigher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancyen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Diabetes Investigationen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationMenzies School of Health Research, Darwin, Northern Territory, Australiaen_US
dc.identifier.affiliationDepartment of Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Chemical Pathology, Melbourne Pathology, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Medicine, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationMercy Hospital for Women, Heidelberg, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/28129477en_US
dc.identifier.doi10.1111/jdi.12634en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-2372-395Xen_US
dc.type.austinJournal Articleen_US
local.name.researcherChurilov, Leonid
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

88
checked on Dec 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.